ACADIA Pharmaceuticals Inc. vs Adecoagro SA — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.55 (market cap $5.07B), while Adecoagro SA trades at $9.67 (market cap $1.36B). The key difference: ACADIA Pharmaceuticals Inc. is far larger — about 3.7× Adecoagro SA's market cap, and Adecoagro SA pays a 3.15% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | AGRO | |
|---|---|---|
Market Cap | $5.07B | $1.36B |
Sector | Health | Technology |
52-Week High | $29.41 | $15.25 |
52-Week Low | $20.06 | $7.13 |
Enterprise Value | $4.19B | $3.39B |
Dividend Yield | — | 3.15% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Adecoagro is a South American agricultural company. It operates a diversified business including farming crops, rice, and dairy, as well as producing sugar, ethanol, and renewable energy from its industrial facilities.
Read more on AGRO →